Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger

cafead

Administrator
Staff member
  • cafead   Feb 10, 2025 at 10:32: AM
via Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up the portfolio ahead of its merger with TuHURA Biosciences, the biotech has agreed to sell the deals to an investment firm, offload a pain prospect to Pacira Pharmaceuticals and scrap its pact with GigaGen.

article source